BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11733962)

  • 1. Papillary serous carcinoma of the uterus: increased risk of subsequent or concurrent development of breast carcinoma.
    Geisler JP; Sorosky JI; Duong HL; Buekers TE; Geisler MJ; Sood AK; Anderson B; Buller RE
    Gynecol Oncol; 2001 Dec; 83(3):501-3. PubMed ID: 11733962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between tamoxifen use and high risk endometrial cancer histologic types.
    Bland AE; Calingaert B; Secord AA; Lee PS; Valea FA; Berchuck A; Soper JT; Havrilesky L
    Gynecol Oncol; 2009 Jan; 112(1):150-4. PubMed ID: 18937966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer.
    Santin AD; Diamandis EP; Bellone S; Soosaipillai A; Cane S; Palmieri M; Burnett A; Roman JJ; Pecorelli S
    Clin Cancer Res; 2005 May; 11(9):3320-5. PubMed ID: 15867230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between uterine serous carcinoma and breast cancer.
    Gehrig PA; Bae-Jump VL; Boggess JF; Groben PA; Fowler WC; Van Le L
    Gynecol Oncol; 2004 Jul; 94(1):208-11. PubMed ID: 15262144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas.
    Sherman ME; Sturgeon S; Brinton LA; Potischman N; Kurman RJ; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD
    Mod Pathol; 1997 Oct; 10(10):963-8. PubMed ID: 9346174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer followed by corpus cancer: is there a higher risk for aggressive histologic subtypes?
    Chan JK; Manuel MR; Cheung MK; Osann K; Husain A; Teng NN; Rao A; Carlson RW; Whittemore AS
    Gynecol Oncol; 2006 Sep; 102(3):508-12. PubMed ID: 16483640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine papillary serous carcinoma: patterns of metastatic spread.
    Goff BA; Kato D; Schmidt RA; Ek M; Ferry JA; Muntz HG; Cain JM; Tamimi HK; Figge DC; Greer BE
    Gynecol Oncol; 1994 Sep; 54(3):264-8. PubMed ID: 8088602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Uterine papillary serous carcinoma and papillary endometrial carcinoma: analysis of clinical biological behaviors of 56 cases].
    Sun X; Shi S; Sheng X
    Zhonghua Fu Chan Ke Za Zhi; 1996 Jan; 31(1):8-11. PubMed ID: 8758810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinico-cytological study of uterine papillary serous carcinoma.
    Hagiwara T; Kaku T; Kobayashi H; Hirakawa T; Nakano H
    Cytopathology; 2005 Jun; 16(3):125-31. PubMed ID: 15924607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High serum levels of interleukin-6 in endometrial carcinoma are associated with uterine serous papillary histology, a highly aggressive and chemotherapy-resistant variant of endometrial cancer.
    Bellone S; Watts K; Cane' S; Palmieri M; Cannon MJ; Burnett A; Roman JJ; Pecorelli S; Santin AD
    Gynecol Oncol; 2005 Jul; 98(1):92-8. PubMed ID: 15904949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium.
    Creasman WT; Kohler MF; Odicino F; Maisonneuve P; Boyle P
    Gynecol Oncol; 2004 Dec; 95(3):593-6. PubMed ID: 15581969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas.
    Santin AD; Diamandis EP; Bellone S; Marizzoni M; Bandiera E; Palmieri M; Papasakelariou C; Katsaros D; Burnett A; Pecorelli S
    Am J Obstet Gynecol; 2006 May; 194(5):1296-302. PubMed ID: 16647913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrioid carcinoma simultaneously involving the uterus and the fallopian tube: a clinicopathologic study of 13 cases.
    Culton LK; Deavers MT; Silva EG; Liu J; Malpica A
    Am J Surg Pathol; 2006 Jul; 30(7):844-9. PubMed ID: 16819326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stage I ovarian carcinoma: different clinical pathologic patterns.
    Deligdisch L; Pénault-Llorca F; Schlosshauer P; Altchek A; Peiretti M; Nezhat F
    Fertil Steril; 2007 Oct; 88(4):906-10. PubMed ID: 17920404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Uterine papillary serous carcinoma--one kind of special type of uterine endometrial carcinoma].
    Wu M; Lang J; Guo L
    Zhonghua Fu Chan Ke Za Zhi; 1996 Jan; 31(1):3-7. PubMed ID: 8758809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Papillary serous carcinoma of the peritoneum coexisting with or after endometrial carcinoma.
    Altaras MM; Bernheim J; Zehavi T; Drucker L; Uziel O; Fishman A
    Gynecol Oncol; 2002 Feb; 84(2):245-51. PubMed ID: 11812082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic characterization of uterine papillary serous adenocarcinoma.
    Miller B; Umpierre S; Tornos C; Burke T
    Gynecol Oncol; 1995 Mar; 56(3):425-9. PubMed ID: 7705679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial carcinoma: the prognostic impact of papillary serous carcinoma (UPSC) in relation to nuclear grade, DNA ploidy and p53 expression.
    Nordström B; Strang P; Lindgren A; Bergström R; Tribukait B
    Anticancer Res; 1996; 16(2):899-904. PubMed ID: 8687148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What staging surgery should be performed on patients with uterine papillary serous carcinoma?
    Geisler JP; Geisler HE; Melton ME; Wiemann MC
    Gynecol Oncol; 1999 Sep; 74(3):465-7. PubMed ID: 10479511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer.
    Maxwell GL; Chandramouli GV; Dainty L; Litzi TJ; Berchuck A; Barrett JC; Risinger JI
    Clin Cancer Res; 2005 Jun; 11(11):4056-66. PubMed ID: 15930340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.